Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ypsomed Holding AGXSWX:YPSN -7.18%92 Shiller PE Ratio is 71.95 as of Sep. 13, 2026, which is 14% below its 10-year median of 83.21. GuruFocus rates XSWX:YPSN with a GF Score™ of 92/100 and a GF Value™ of CHF394.22 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 313 Medical Devices & Instruments companies, Ypsomed Holding AG ranks worse than 89.14% on this metric.
The historical rank and industry rank for Ypsomed Holding AG's Shiller PE Ratio or its related term are showing as below:
XSWX:YPSN'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 54.78 Med: 83.21 Max: 161.37
Current: 71.91
During the past 13 years, Ypsomed Holding AG's highest Shiller PE Ratio was 161.37. The lowest was 54.78. And the median was 83.21.
XSWX:YPSN's Shiller PE Ratio is ranked worse than 89.14% of 313
companies
in the Medical Devices & Instruments industry
Industry Median: 24.56
vs XSWX:YPSN: 71.91
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
Ypsomed Holding AG's adjusted earnings per share data of for the fiscal year that ended in Mar26 was CHF16.300. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is CHF4.92 for the trailing ten years ended in Mar26.
Shiller PE for Stocks: The True Measure of Stock Valuation
Ypsomed Holding AG (XSWX:YPSN) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
Ypsomed Holding AG Shiller PE Ratio Related Terms
Ypsomed Holding AG Shiller PE Ratio Historical Data
* Premium members only.
The historical data trend for Ypsomed Holding AG's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:YPSN vs ISRG, BDX, RMD: Shiller PE Ratio Comparison
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG Shiller PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's Shiller PE Ratio falls into.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Ypsomed Holding AG (XSWX:YPSN) has a Shiller PE Ratio of 71.95 as of Sep. 13, 2026. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Ypsomed Holding AG and its competitors. This is 14% below median its historical median of 83.21. Over the past decade, Ypsomed Holding AG's Shiller PE Ratio has ranged from 54.78 to 161.37. According to the industry distribution chart, Ypsomed Holding AG ranks #279 out of 313 companies in the Medical Devices & Instruments industry, placing it in the top 89.1%.
Is Ypsomed Holding AG's Shiller PE Ratio too high?
Ypsomed Holding AG's current Shiller PE Ratio of 71.95 is 14% below median its 10-year median of 83.21. Over the past 10 years, this metric has ranged from a low of 54.78 to a high of 161.37. The Medical Devices & Instruments industry median Shiller PE Ratio is 24.56. Ypsomed Holding AG's value of 71.95 is 193% above this industry median. Based on the distribution chart, Ypsomed Holding AG ranks #279 out of 313 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ypsomed Holding AG has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Shiller PE Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #279 out of 313 companies for Shiller PE Ratio. This places Ypsomed Holding AG in the lower half of its industry. The industry median Shiller PE Ratio is 24.56. Ypsomed Holding AG's value of 71.95 is 193% above this benchmark. Historically, Ypsomed Holding AG's own Shiller PE Ratio has ranged from 54.78 to 161.37 over the past decade. While the company's 10-year median is 83.21 vs. the industry median of 24.56, Ypsomed Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shiller PE Ratio for a Medical Devices & Instruments company?
The median Shiller PE Ratio among Medical Devices & Instruments companies is 24.56, based on 313 companies in the industry. Companies in the top quartile (top 25%) have a Shiller PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Shiller PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ypsomed Holding AG's current Shiller PE Ratio of 71.95 is 193% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shiller PE Ratio mean?
A high Shiller PE Ratio can signal that a stock is expensive relative to its fundamentals. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Ypsomed Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Shiller PE Ratio is 24.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ypsomed Holding AG's current Shiller PE Ratio is 71.95, which is 14% below median its own 10-year median of 83.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF394.22, compared to a current price of CHF354.00 — trading 10.2% below its estimated fair value. The current Shiller PE Ratio is 71.95, which is 14% below median its 10-year median of 83.21 and 193% above the Medical Devices & Instruments industry median of 24.56. Ypsomed Holding AG's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shiller PE Ratio calculated?
Shiller PE Ratio is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current Shiller PE Ratio is 71.95 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?
Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued.
The current stock price of CHF354.00 is trading 10.2% below its estimated GF Value™ of CHF394.22.
GuruFocus considers Ypsomed Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:YPSN:
Shiller PE Ratio: 71.95 (14% below median its 10-year median of 83.21)
GF Value™: CHF394.22 vs. price of CHF354.00 (10.2% below fair value)
Industry Position: 193% above the Medical Devices & Instruments median (#279 of 313)
No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
92GF Score
Get the complete analysis for XSWX:YPSN
Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:YPSN has been successfully added to your 
